The American health care system is in the midst of great change. In the past, public and private payors alike paid health care providers on a treatment by treatment basis – a so-called “fee for service” approach.
Now, however, payors are increasingly moving toward a value-based model, where providers are responsible not only for the quality of health care they provide patients, but also the cost of these services. In short, only providers who are able to provide the highest quality care in the most efficient way possible will become providers of choice in the emerging health care system.
Through its intensive care coordination and disease management services, Fresenius Health Partners, a wholly-owned subsidiary of Fresenius Medical Care North America, is poised to deliver on the promise of this new model. By partnering with government payors, private health plans and accountable care organizations, Fresenius Health Partners is working to improve the health and outcomes of kidney patients while at the same time reducing the total cost of their care.